The company presented new data on the PGx test this week and expressed confidence that they can secure broader payor coverage for it.
The centers are using the standardized pipeline to help streamline data sharing and data analysis to achieve their larger research goals.
The deal will grant Myriad entry into the neuroscience space, and will allow it to use Assurex's existing sales force to market its own mental health tests.
The firm plans to launch testing in the US this fall through Atlanta-based Alpha Genomix, and is looking for similar partners in Asia for a new Asia-specific panel.
Researchers identified Neanderthal alleles associated with human conditions using genotypic and phenotypic information in health records for more than 28,000 individuals.
The RNA products developer is buying California-based Narus in order to expand into the RNA-based diagnostics market.
Following from genetic studies of compulsive behavior in dogs, researchers have starting collecting behavioral information for dogs in the Darwin's Dogs project.
Researchers tracked one individual's brain imaging patterns, physical features, blood metabolomics, gene expression, and more.
The mental health-focused testing firm plans to use the money to conduct additional studies for Genecept and develop a next-generation product.
The effort will compare the outcomes and healthcare costs of patients whose treatments were informed by genetic testing results against those managed without this information.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.